Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1328 of 5804
-
New study aims to close cancer care gap for indigenous americans
Knowledge-focused Recruiting nowThis clinical trial is studying the genetic changes in cells associated with different types of cancer in Indigenous American (IA) populations in the Southwest to improve cancer screening, precision prevention, and therapeutic intervention for individual in these communities. IA …
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Diabetes study tests team support for better blood sugar control
Disease control ENROLLING_BY_INVITATIONContinuous glucose monitoring (CGM) can help improve blood sugar management in type 2 diabetes. A sequential, multiple assignment, randomized trial will evaluate clinical pharmacists, community health workers, and telehealth in supporting CGM use to improve blood sugar control.
Phase: NA • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug TZIELD aims to delay type 1 diabetes – but is it safe long-term?
Disease control Recruiting nowStage 2 Type 1 Diabates (T1D) is an early stage of T1D characterized by dysglycemia but not yet leading to clinical symptoms. Progression of the disease to Stage 3 (clinical T1D), leads to overt hyperglycemia requiring eventually exogenous insulin. TZIELD® (teplizumab-mzwv) has …
Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Asthma care goes to school: new study tests In-School treatment to cut attacks
Disease control Recruiting nowChildren with asthma from communities that experience health inequities frequently do not receive guideline-based asthma care, and as a result, account for a disproportionate percentage of asthma exacerbations, emergency department visits, and hospitalizations. Project ASTHMA (Al…
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
AI app aims to get oral cancer patients back to work
Symptom relief Recruiting nowThe goal of this clinical trial is to develop and evaluate an Artificial Intelligence Assisted Prehabilitation Program (AI APP) for returning to work and cost-effectiveness analysis in patients with oral cancer (OC). The main questions it aims to answer are: * What kinds of need…
Phase: NA • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Weight loss program could open door to kidney transplants for obese patients
Disease control Recruiting nowOK-TRANSPLANT 2 is a vanguard study for a large randomized, pragmatic, open-label trial. We will randomize participants with obesity, high-risk CKD/dialysis who are hoping for lose weight for the purpose of kidney transplant. Subjects will either be enrolled on a virtual weight …
Phase: PHASE4 • Sponsor: Western University, Canada • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug trial hopes to tame rare skin disease
Disease control Recruiting nowThis is a first-in-human, Phase 1/1b, 4-part study that includes the evaluation of safety, tolerability, pharmacokinetics (PK), and immunogenicity of BCX17725 when administered via single and multiple doses in healthy adult participants (Parts 1 and 2), and multiple doses in adul…
Phase: PHASE1 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Radiation reduction trial aims to boost quality of life for head and neck cancer survivors
Disease control Recruiting nowTo explore the control rate and quality of life of participants with late head and neck squamous cell carcinoma who have obtained postoperative pCR after cervical lymph node surgery with neoadjuvant chemotherapy combined with immunotherapy, and the cervical lymph node removal pro…
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New pill combo aims to tame advanced prostate cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, and safety of HRS-5041 tablets combined with antitumor therapy in subjects with advanced prostate cancer.
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hearing implant shows promise for kids under five
Disease control CompletedThis study, titled "The BONEBRIDGE in Children Under Five: Premarket Clinical Investigation" (Study ID 2023BB006), looks at kids under five who have received the BONEBRIDGE BCI 602 hearing implant. This observational study, which is both retrospective (looking back) and prospecti…
Sponsor: MED-EL Elektromedizinische Geräte GesmbH • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Taurine trial: could this common supplement turn back the clock?
Symptom relief CompletedThe goal of this clinical trial is to investigate the effect of taking 4 grams of taurine by older adults on aging processes over a period of 6 months. It will also check for effects of taurine on participant's physical fitness, metabolic and cognitive functions. The main questio…
Phase: NA • Sponsor: Technical University of Munich • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New patch could replace opioids for knee surgery pain
Symptom relief CompletedThis is a randomized (1:1) placebo-controlled clinical trial to determine the feasibility and effectiveness of 30-day application of NEUROCUPLE™ patch for pain reduction and opioid consumption following TKA. Results will establish NEUROCUPLE™ as an effective non-opioid postoperat…
Phase: NA • Sponsor: nCap Medical • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New scan could spot bile duct cancers more accurately
Diagnosis Recruiting nowThe goal of this prospective observational study is to evaluate whether Gallium-68 Fibroblast Activation Protein Inhibitor (FAPI) PET/CT can improve detection, staging, and recurrence assessment in adult patients (≥18 years) with suspected or confirmed biliary tract cancers, incl…
Sponsor: Tata Memorial Centre • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Can ashwagandha boost chemo in ovarian cancer? new trial aims to find out
Disease control Recruiting nowThe proposed study "combination therapy with liposomal doxorubicin and withaferin A (Ashwagandha, ASWD) in recurrent ovarian cancer" is focused to determine the feasibility and maximum tolerance dose of Ashwagandha with liposomal doxorubicin (DOXIL) in recurrent ovarian cancer pa…
Phase: PHASE1, PHASE2 • Sponsor: Sham Sunder Kakar • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug combo aims to stall endometrial cancer in High-Risk patients
Disease control Recruiting nowThe purpose of this research study is to see if the study drugs abemaciclib and letrozole are effective and safe for participants with estrogen-receptor positive (ER+), mismatch repair proficient, tumor protein p53 (TP53) wild-type endometrial cancer. The names of the study drug…
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug duo aims to shrink head and neck tumors
Disease control Recruiting nowThe purpose of the study is to determine the activity and safety of ACR-368 (prexasertib) in combination with gemcitabine in participants with Head and Neck Squamous Cell Carcinoma (HNSCC). Participants will receive the study drugs ACR-368 and a low dose of gemcitabine once every…
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New study tracks long-term safety of DMD drug vamorolone in boys
Disease control Recruiting nowThe goal of this study is to collect additional information on the safety of long-term treatment with AGAMREE® and to explore long-term clinical impact of AGAMREE® on quality of life, as assessed by standardized patient-reported outcome measures (QoL questionnaires) in male patie…
Sponsor: Catalyst Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New scan could predict breast cancer treatment success in days
Diagnosis Recruiting nowThis clinical trial will investigate an estrogen-regulated parameter as an early measure of endocrine therapy response: progesterone receptor (PR) protein with a progestin-based radioligand, 18F-fluorofuranylnorprogesterone (18F-FFNP). The overall purpose of this research is to t…
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
Lifestyle makeover may stop prediabetes in its tracks
Prevention CompletedDiabetes mellitus is a major global health challenge, with type 2 diabetes (T2DM) accounting for nearly 90% of all cases worldwide. In Egypt, diabetes prevalence among adults is high (15.2%), with approximately 10.9 million people currently affected and projections estimating a r…
Phase: PHASE4 • Sponsor: Kasr El Aini Hospital • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
New heart procedure tested for AFib control
Disease control OngoingThe ADVENT Post Approval Study (PAS) is a prospective, global, multicenter, observational study.
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC